Nationwide Fund Advisors’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
Other funds holding XENT
DM
Nationwide Fund Advisors's XENT Position: Q4 2017 in Review
Nationwide Fund Advisors sold out of Intersect ENT, Inc (XENT) in Q4 2017, closing a stake of 56,901 shares — an estimated $1.77M sold.
Nationwide Fund Advisors first reported a position in XENT in Q3 2014 and held it in 13 quarters. The position peaked at $4.47M in Q4 2015. 157 funds tracked by Wall St. Rank hold XENT as of Q4 2017.
- Nationwide Fund Advisors reported no remaining Intersect ENT, Inc position as of Q4 2017 after selling out during the quarter.
- Nationwide Fund Advisors sold 56,901 Intersect ENT, Inc shares in Q4 2017, an estimated $1.77M.
- Nationwide Fund Advisors first reported a position in Intersect ENT, Inc in Q3 2014 and held it in 13 quarters.
- Nationwide Fund Advisors's Intersect ENT, Inc position peaked at $4.47M in Q4 2015.
- 157 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q4 2017.
Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.